European Endocrinology

1.2(top 50%)

impact factor

450(top 50%)

papers

2.1K(top 50%)

citations

21(top 50%)

h-index

1.3(top 50%)

impact factor

530

all documents

2.3K

doc citations

33(top 50%)

g-index

Top Articles

#	Title	Journal	Year	Citations
1	A Review of the Pharmacokinetics of Levothyroxine for the Treatment of Hypothyroidism	European Endocrinology	2010	110
2	The Importance of Energy Balance	European Endocrinology	2010	77
3	Male Obesity-related Secondary Hypogonadism – Pathophysiology, Clinical Implications and Management	European Endocrinology	2019	76
4	Ghrelin – Physiological Functions and Regulation	European Endocrinology	2015	61
5	Role of Mitotane in Adrenocortical Carcinoma – Review and State of the art	European Endocrinology	2018	58
6	Updates in Diagnosis and Treatment of Acromegaly	European Endocrinology	2018	56
7	Non-pharmacological Treatment Options in the Management of Diabetes Mellitus	European Endocrinology	2018	50
8	Selecting the Appropriate Continuous Glucose Monitoring System – a Practical Approach	European Endocrinology	2018	43
9	The DFUC 2020 Dataset: Analysis Towards Diabetic Foot Ulcer Detection	European Endocrinology	2021	43
10	Functioning Pituitary Adenomas – Current Treatment Options and Emerging Medical Therapies	European Endocrinology	2019	42
11	Factors Determining the Success of Therapeutic Lifestyle Interventions in Diabetes – Role of Partner and Family Support	European Endocrinology	2019	36
12	‘Too Much Sitting’ and Metabolic Risk – Has Modern Technology Caught Up with Us?	European Endocrinology	2010	33
13	Early Vascular Ageing – A Concept in Development	European Endocrinology	2015	30
14	Recombinant Human Insulins – Clinical Efficacy and Safety in Diabetes Therapy	European Endocrinology	2016	27
15	Advances in Type 1 Diabetes Technology Over the Last Decade	European Endocrinology	2019	27
16	Mind–Body Interactions and Mindfulness Meditation in Diabetes	European Endocrinology	2018	26
17	The Cardiovascular Benefits Associated with the Use of Sodium-glucose Cotransporter 2 Inhibitors – Real-world Data	European Endocrinology	2018	26
18	Male Central Hypogonadism in Paediatrics – the Relevance of Follicle-stimulating Hormone and Sertoli Cell Markers	European Endocrinology	2018	25
19	Exercise is Medicine—The Importance of Physical Activity, Exercise Training, Cardiorespiratory Fitness and Obesity in the Prevention and Treatment of Type 2 Diabetes	European Endocrinology	2014	25
20	Skin Autofluorescence – A Non-invasive Measurement for Assessing Cardiovascular Risk and Risk of Diabetes	European Endocrinology	2014	24
21	Clinical Safety and Tolerability of Vildagliptin – Insights from Randomised Trials, Observational Studies and Post-marketing Surveillance	European Endocrinology	2017	23
22	The Emerging Health Benefits of Coffee with an Emphasis on Type 2 Diabetes and Cardiovascular Disease	European Endocrinology	2010	22
23	Cost-effectiveness Analysis of a Flash Glucose Monitoring System for Patients with Type 1 Diabetes Receiving Intensive Insulin Treatment in Sweden	European Endocrinology	2018	22
24	Anticancer Drug-induced Thyroid Dysfunction	European Endocrinology	2020	22
25	The Prevalence and Predictors of Non-alcoholic Fatty Liver Disease in Morbidly Obese Women – A Cross-sectional Study from Southern India	European Endocrinology	2020	22
26	Co-existing Non-communicable Diseases and Mental Illnesses Amongst the Elderly in Punjab, India	European Endocrinology	2019	21
27	Equivalent Recombinant Human Insulin Preparations and their Place in Therapy	European Endocrinology	2015	20
28	Second-generation Insulin Analogues – a Review of Recent Real-world Data and Forthcoming Head-to-head Comparisons	European Endocrinology	2018	20
29	Sarcopenia in the Elderly	European Endocrinology	2019	19
30	Bone Involvement in Primary Hyperparathyroidism and Changes After Parathyroidectomy	European Endocrinology	2010	19
31	Clinical Presentation and Outcomes of Phaeochromocytomas/Paragangliomas in Neurofibromatosis Type 1	European Endocrinology	2019	19
32	Insulin Injection Practice and Injection Complications – Results from the Bangladesh Insulin Injection Technique Survey	European Endocrinology	2020	19
33	Self-measurement of Blood Glucose and Continuous Glucose Monitoring – Is There Only One Future?	European Endocrinology	2018	18
34	Hypoglycaemia Remains the Key Obstacle to Optimal Glycaemic Control – Continuous Glucose Monitoring is the Solution	European Endocrinology	2018	17
35	Obstructive Sleep Apnoea and Vascular Disease in Patients with Type 2 Diabetes	European Endocrinology	2015	17
36	Person-centred Obesity Care – Techniques, Thresholds, Tools and Targets	European Endocrinology	2020	17
37	EPODE – A Model for Reducing the Incidence of Obesity and Weight-related Comorbidities	European Endocrinology	2010	16
38	Gliptin Therapies for Inhibiting Dipeptidyl Peptidase-4 in Type 2 Diabetes	European Endocrinology	2010	16
39	Insulin Glulisine in Pregnancy – Experience from Clinical Trials and Post-marketing Surveillance	European Endocrinology	2015	16
40	The Cost-effectiveness of a Flash Glucose Monitoring System for Management of Patients with Type 2 Diabetes Receiving Intensive Insulin Treatment in Sweden	European Endocrinology	2018	16
41	A Comparative Pulse Accuracy Study of Two Commercially Available Patch Insulin Infusion Pumps	European Endocrinology	2016	15
42	The Role of Visceral Adipose Tissue in the Pathogenesis of Non-alcoholic Fatty Liver Disease	European Endocrinology	2010	15
43	A Comparison of Insulin Pen Devices and Disposable Plastic Syringes – Simplicity, Safety, Convenience and Cost Differences	European Endocrinology	2018	14
44	Resveratrol for the Management of Diabetes and its Downstream Pathologies	European Endocrinology	2010	14
45	Cardiovascular Risk in Patients with Subclinical Hypothyroidism	European Endocrinology	2014	14
46	Empagliflozin and Cardio-renal Outcomes in Patients with Type 2 Diabetes and Cardiovascular Disease – Implications for Clinical Practice	European Endocrinology	2018	13
47	Obstructive Sleep Apnoea and Type 2 Diabetes	European Endocrinology	2010	13
48	Cost Calculation for a Flash Glucose Monitoring System for Adults With Type 2 Diabetes Mellitus Using Intensive Insulin – a UK Perspective	European Endocrinology	2018	13
49	Friendly Fat Theory – Explaining the Paradox of Diabetes and Obesity	European Endocrinology	2019	13
50	Diabetic Polyneuropathy – Advances in Diagnosis and Intervention Strategies	European Endocrinology	2020	13

Scientometrics

Overviews

Citing Bodies

European Endocrinology

Top Articles